Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | aldehyde dehydrogenase | 0.012 | 0.2401 | 0.6788 |
Brugia malayi | MAP kinase sur-1 | 0.0158 | 0.3414 | 1 |
Brugia malayi | beta-lactamase family protein | 0.004 | 0.0259 | 0.0759 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0259 | 0.0759 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0158 | 0.3414 | 0.3239 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.004 | 0.0259 | 0.0759 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0158 | 0.3414 | 0.5262 |
Trypanosoma brucei | protein kinase, putative | 0.0158 | 0.3414 | 0.5312 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0158 | 0.3414 | 0.5312 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.012 | 0.2401 | 0.8054 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0158 | 0.3414 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0043 | 0.0342 | 0.0261 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0158 | 0.3414 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.012 | 0.2401 | 0.3572 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.004 | 0.0259 | 0.0759 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0044 | 0.0368 | 0.1078 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0158 | 0.3414 | 0.5262 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0158 | 0.3414 | 0.5312 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0265 | 0.6255 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0158 | 0.3414 | 0.5312 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0158 | 0.3414 | 0.5 |
Mycobacterium leprae | Probable lipase LipE | 0.004 | 0.0259 | 0.5 |
Brugia malayi | beta-lactamase | 0.004 | 0.0259 | 0.0759 |
Mycobacterium leprae | conserved hypothetical protein | 0.004 | 0.0259 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0.0259 | 0.0105 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.012 | 0.2401 | 0.8054 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.012 | 0.2401 | 0.8054 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0158 | 0.3414 | 1 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0125 | 0.2541 | 0.3806 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0045 | 0.0413 | 0.0358 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0259 | 0.0759 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0158 | 0.3414 | 1 |
Onchocerca volvulus | 0.004 | 0.0259 | 0.5 | |
Loa Loa (eye worm) | beta-lactamase | 0.004 | 0.0259 | 0.0759 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0259 | 0.0759 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0265 | 0.6255 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0158 | 0.3414 | 1 |
Onchocerca volvulus | 0.004 | 0.0259 | 0.5 | |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.004 | 0.0259 | 0.0759 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.012 | 0.2401 | 0.7032 |
Onchocerca volvulus | 0.004 | 0.0259 | 0.5 | |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0158 | 0.3414 | 0.3239 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0158 | 0.3414 | 0.3239 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0259 | 0.0759 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.012 | 0.2401 | 0.7032 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0265 | 0.6255 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0044 | 0.0368 | 0.1078 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0158 | 0.3414 | 0.3239 |
Trypanosoma brucei | hypothetical protein, conserved | 0.004 | 0.0259 | 0.0105 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0.0259 | 0.0105 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.012 | 0.2401 | 0.2199 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0368 | 0.1078 |
Mycobacterium ulcerans | hypothetical protein | 0.0139 | 0.2918 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0265 | 0.6255 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0158 | 0.3414 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.004 | 0.0259 | 0.0759 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.012 | 0.2401 | 0.3768 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0253 | 0.5943 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.012 | 0.2401 | 0.2199 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0259 | 0.0759 |
Brugia malayi | beta-lactamase family protein | 0.004 | 0.0259 | 0.0759 |
Plasmodium vivax | hypothetical protein, conserved | 0.004 | 0.0259 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0044 | 0.0368 | 0.1078 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0158 | 0.3414 | 0.5312 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0139 | 0.2918 | 0.4678 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0158 | 0.3414 | 0.5312 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0125 | 0.2541 | 0.3871 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0259 | 0.0759 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0158 | 0.3414 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0125 | 0.2541 | 0.3871 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.